GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $21.93 $29.93 Thursday, 18th Apr 2024 ARWR stock ended at $22.61. This is 0.355% more than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 3.97% from a day low at $21.93 to a day high of $22.80.
90 days $21.93 $36.72
52 weeks $20.67 $42.48

Historical Arrowhead Research Corporation prices

Date Open High Low Close Volume
2020-10-22 $57.27 $59.85 $57.01 $58.56 1 647 486
2020-10-21 $54.79 $58.50 $54.42 $56.72 2 046 657
2020-10-20 $50.08 $54.94 $49.50 $54.74 1 868 513
2020-10-19 $49.18 $52.00 $48.21 $50.08 1 618 100
2020-10-16 $48.85 $50.70 $48.39 $49.38 1 202 840
2020-10-15 $48.19 $50.86 $46.11 $48.85 4 010 190
2020-10-14 $46.27 $46.71 $44.29 $44.46 664 556
2020-10-13 $46.18 $47.19 $45.65 $46.52 641 108
2020-10-12 $46.67 $47.01 $45.14 $46.39 690 475
2020-10-09 $48.21 $48.59 $45.79 $46.05 992 420
2020-10-08 $51.34 $51.34 $47.24 $48.01 1 893 888
2020-10-07 $46.42 $48.34 $46.21 $48.10 528 293
2020-10-06 $46.97 $48.46 $46.08 $46.41 874 988
2020-10-05 $44.19 $47.27 $44.19 $47.11 1 120 048
2020-10-02 $43.75 $44.70 $42.44 $43.82 995 534
2020-10-01 $43.12 $45.44 $42.97 $44.76 1 004 040
2020-09-30 $43.64 $44.36 $42.65 $43.06 906 274
2020-09-29 $43.61 $44.29 $43.22 $43.42 818 884
2020-09-28 $45.17 $45.17 $42.40 $43.68 1 076 322
2020-09-25 $43.98 $45.10 $43.65 $44.92 847 374
2020-09-24 $44.17 $45.73 $42.99 $44.31 855 709
2020-09-23 $43.51 $45.82 $43.28 $44.64 1 736 044
2020-09-22 $42.25 $44.10 $41.60 $43.80 1 419 762
2020-09-21 $41.67 $43.56 $41.26 $41.71 1 294 300
2020-09-18 $46.47 $46.49 $41.76 $43.10 4 014 432
Click to get the best stock tips daily for free!

About Arrowhead Research Corporation

Arrowhead Research Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, which is in phase 2b and one phase 3 clinical trial to treat hypertriglyceridemia; ARO-ANG3 that is in P... ARWR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT